Tenaya Therapeutics Inc
TNYA
Company Profile
Business description
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
Contact
171 Oyster Point Boulevard
Suite 500
South San FranciscoCA94080
USAT: +1 650 825-6990
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
97
Stocks News & Analysis
stocks
Is AUB an opportunity after shares plunge 17%?
After a takeover bid was withdrawn shares dropped to below the pre-bid price.
stocks
Attractive ASX listed income opportunity
A high forward distribution yield may entice income investors.
stocks
Have the 3 biggest losers of the ASX 200 fallen too far?
Finding value in some of the ASX’s worst recent performers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,870.50 | 15.50 | -0.17% |
| CAC 40 | 8,097.00 | 25.71 | -0.32% |
| DAX 40 | 23,589.44 | 247.35 | -1.04% |
| Dow JONES (US) | 47,289.33 | 427.09 | -0.90% |
| FTSE 100 | 9,702.53 | 17.98 | -0.18% |
| HKSE | 26,047.74 | 14.48 | 0.06% |
| NASDAQ | 23,275.92 | 89.76 | -0.38% |
| Nikkei 225 | 49,502.24 | 198.96 | 0.40% |
| NZX 50 Index | 13,516.77 | 68.28 | 0.51% |
| S&P 500 | 6,812.63 | 36.46 | -0.53% |
| S&P/ASX 200 | 8,573.60 | 13.70 | -0.16% |
| SSE Composite Index | 3,892.55 | 21.46 | -0.55% |